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Abstract
Genetic mapping studies may provide association between sequence variants and disease susceptibility that can, with
further experimental and computational analysis, lead to discovery of causal mechanisms and effective intervention. We
have previously demonstrated that polymorphisms in immunity-related GTPases (IRG) confer a significant difference in
susceptibility to Chlamydia psittaci infection in BXD recombinant mice. Here we combine genetic mapping and network
modeling to identify causal pathways underlying this association. We infected a large panel of BXD strains with C. psittaci
and assessed host genotype, IRG protein polymorphisms, pathogen load, expression of 32 cytokines, inflammatory cell
populations, and weight change. Proinflammatory cytokines correlated with each other and were controlled by a novel
genetic locus on chromosome 1, but did not affect disease status, as quantified by weight change 6 days after infection In
contrast, weight change correlated strongly with levels of inflammatory cell populations and pathogen load that were
controlled by an IRG encoding genetic locus (Ctrq3) on chromosome 11. These data provided content to generate a
predictive model of infection using a Bayesian framework incorporating genotypes, immune system parameters, and weight
change as a measure of disease severity. Two predictions derived from the model were tested and confirmed in a second
round of experiments. First, strains with the susceptible IRG haplotype lost weight as a function of pathogen load whereas
strains with the resistant haplotype were almost completely unaffected over a very wide range of pathogen load. Second,
we predicted that macrophage activation by Ctrq3 would be central in conferring pathogen tolerance. We demonstrated
that macrophage depletion in strains with the resistant haplotype led to neutrophil influx and greater weight loss despite a
lower pathogen burden. Our results show that genetic mapping and network modeling can be combined to identify causal
pathways underlying chlamydial disease susceptibility.
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Introduction
The genus Chlamydia comprises a number of species of highly
related obligate intracellular prokaryotic pathogens that cause
clinical disease in humans ranging from blinding trachoma [1] and
sexually transmitted infection by Chlamydia trachomatis [2], com-
munity acquired pneumonia by Chlamydia pneumoniae [3] and life-
threatening respiratory and systemic zoonosis by Chlamydia psittaci
[4]. In a previous study, we determined that a known QTL on
chromosome 11 (Ctrq3) [5,6] containing two polymorphic innate
immune genes (Irgm2 and Irgb10) in the family of immunity-related
GTPases (IRG) were responsible for the innate difference in
susceptibility to a systemic infection to C. psittaci among the BXD
recombinant inbred strains [7]. Each member of this mouse
reference strain set inherits a unique and approximately equal
fraction of their genomes from two fully inbred progenitors—
strain C57BL/6J (B6 or B) and DBA/2J (D2 or D). These two
parental strains differ at roughly 5 million sites across the genome.
The set of 80 BXD strains is being used for systematic multiscalar
genetic studies of host-pathogen interactions [8,9,10]. This large
set of genetically related strains can provide comparatively high
precision mapping, with a resolution of 1–2 Mb in several cases
[7,11]. Characterization of the disease susceptibility differences
between the B6 and D2 parental strains revealed significant
differences in C. psittaci load, inflammatory responses, and cytokine
profiles. While the IRGs have been shown to control Chlamydia
load [6,7,12], alternative immunomodulatory functions of these
genes have also been reported [13,14,15] making it unclear if
IRGs influence disease outcome by regulating pathogen load or by
influencing other immunomodulatory functions [16].
Recent advances in high-throughput genomic technologies and
computational methods allow us to formulate and test genetic
network models without explicit data on molecular function.
Translating large-scale genomic data into network models with
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to systematically evaluate the possible hypothetical network
models against data and then select the most probable models
for experimental validation. The probability of a genetic network
model conditioned on the data can be calculated using Bayesian
network methods. A Bayesian network is a graphic probabilistic
model representing the dependence structure among multiple
interacting variables [17,18,19]. The probabilistic modelling
provides a natural treatment for the stochastic aspects of biological
processes and noisy measurements [20]. Bayesian networks can be
used to integrate prior knowledge and new data to capture and
express causal relationships [21,22,23].
We combined forward genetics and Bayesian network analysis
to model the biological pathway of how Ctrq3 or polymorphisms in
immunity-related GTPases (IRGs) confer susceptibility and
resistance to Chlamydia infection in strains of mice with different
genetic backgrounds. We then predicted how individual mice
would respond to different intervention and validated these
predictions. The model predicted that Ctrq3 confer protection
against disease through macrophage activation, which then
controls pathogen load and neutrophil influx. The factor with
the greatest impact on disease severity, as quantified by weight
change in strains infected with Chlamydia, was predicted to be
neutrophil influx rather than pathogen load. We validated these
predictions experimentally. Thus, our work provides an experi-
mentally validated model for an immune-regulatory function of
the IRG containing Ctrq3 locus in contributing to the control of
systemic C. psittaci infection.
Results
Immune responses and disease severity to Chlamydia
psittaci infection is controlled by two major genetic loci
We infected the C57BL/6J parental strain and 40 BXD strains
intraperitoneally, and measured peak C. psittaci load, levels of
macrophages and neutrophils in the peritoneal cavity, 32 cytokines
on days 3 and 6; and disease status as quantified by the weight
change from the day of infection. Strains exhibited a spectrum of
disease ranging from 30% weight loss to 10% weight gain over 6
days. Significant variation in cytokine protein expression was
detected for 17 of 32 cytokines (all results will be deposited and will
be accessible in GeneNetwork, www.genenetwork.org). We
confirmed that the previously mapped and cloned Ctrq3 locus on
chromosome 11 is a major controller of weight change,
macrophage activation status (MAS), level of neutrophil recruit-
ment, and C. psittaci load on day 6 (Figure 1). A novel secondary
locus was mapped to distal Chr 1 at ,190 Mb. This locus
modulates levels of several key cytokines—GM-CSF, IL1a,
MIP1a, MIP1b, MIP2—but has no effect on disease severity as
measured by weight changes (Figure 2). To further investigate the
influence of the genetic polymorphisms at Ctrq3, we analyzed the
expression pattern of the IRGM2 protein in the peritoneal lavage
specimens from infected BXD strains and found that it had two
distinct band sizes that are directly correlated with the Ctrq3
genotype [7].
Correlation network analysis reveals the immune
phenotypes associated with disease severity
We constructed a correlation network, including cytokines,
genotypes, immune parameters and disease phenotypes (Figure 3).
The network nodes clustered into two groups. The first group
correlated tightly with the Ctrq3 genotype, IRGM2 expression
pattern and several disease-related parameters, including weight
change, macrophage activation status (MAS), pathogen load, and
neutrophil recruitment. A single cytokine, G-CSF, had a high
correlation with weight change and neutrophil level, but was not
controlled by Ctrq3 (Figure 1E. no significant QTL). The second
group comprised the cytokines, many of which are highly
correlated with each other, and the genotype at rs13476293, a
marker located at ,190 Mb on Chr 1, but not directly with
disease-related parameters.
Bayesian network model identifies the central role of
macrophages in the disease pathway
We constructed a Bayesian network model to identify casual
pathways through which genotype at Ctrq3 influences disease
outcome after infection with C. psittaci (Figure 4). The Bayesian
network included variables that were highly correlated with weight
change and influenced by the genotype at Ctrq3: IRGM2
expression pattern, macrophage activation status, neutrophils,
and pathogen load. Because of the perfect correlation between the
Ctrq3 genotype and IRGM2 expression pattern, these variables
were combined into a single node. In the most likely model
structure, the genotype at Ctrq3 was the immediate parent of all of
the other variables in the model, signifying that each of these
variables is directly influenced by the genotype. However, the
model also suggests that Ctrq3 genotype was not sufficient in
explaining these variables, as there were additional conditional
dependencies in the model structure. Weight change, for example,
was directly influenced by neutrophil recruitment and macrophage
activation status (MAS) in addition to genotype at Ctrq3, indicating
that the levels of neutrophils and MAS influences weight change
independent of the Ctrq3 genotype. The model also suggested that
macrophage activation influences weight change via regulation of
neutrophil recruitment but not by pathogen load restriction.
Macrophage and neutrophil influx levels defines disease
severity
We used the Bayesian network model to investigate the effect of
depletion of macrophages on neutrophil influx, C. psittaci load, and
weight change (Figure 5 network C and D). To discretize the
predictions of the model, a threshold was determined by averaging
the mean value of strains with a B genotype and the mean value of
strains with a D genotype for the original data sample. Then, the
probability that the predicted value for each variable was greater
than (High) or less than (Low) this threshold was calculated from
the conditional Gaussian distributions learned from the network
for the original data and after macrophage depletion (Methods).
Nodes with a yellow background have been assigned the value to
represent data for only a given genotype and status of intervention
on MAS. The magnitude of these changes is expected to be much
more pronounced in strains with a B genotype at Ctrq3 than in
strains with a D genotype at this locus. (Figure 5 and Figure S2)
Strains with the D genotype at Ctrq3 typically have innately low
macrophage activation, and as a result the model predicts only
slight changes in the levels of neutrophils, pathogen load, and
weight after depleting macrophages.
We tested these predictions by performing chemical depletion of
macrophages with clodronate before infecting B6 and D2 strains
with C. psittaci. The experiments validated many of the model’s
predictions (Figure 6). In the D2 strain, depletion of macrophages
increased neutrophil influx, C. psittaci load, and induced a more
rapid decline in weight and mice were therefore euthanized on day
4 post infection. Pathogen load in the liver was greater in
macrophage depleted mice by nearly 2 logs (PBS control:
1.21610
5 IFU/gram, Clodronate treated; 9.37610
6 IFU/gram,
p=0.03). As predicted, in the resistant B6 strain, depletion of
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loss. These mice were moribund 5 days post-infection. Pathogen
load in the liver was similar in B6 irrespective of whether
macrophages were depleted or not (PBS control: 4.26610
6 IFU/
gram, Clodronate treated; 3.81610
6 IFU/gram, p=0.06) but
their peritoneal pathogen load was decreased after depleting
macrophages, suggesting that pathogen load restriction may not be
entirely responsible for controlling disease severity.
Ctrq3 confers genetic resistance and tolerance to
Chlamydia
Several reports have documented that IRGs reduce pathogen
burden in vitro and in vivo, which is expected to influence disease
severity [6,7,12,24]. To investigate the possibility that the status of
the Ctrq3 genotype switches disease modality, we performed the
Bayesian analysis for strains with the B genotype at the Ctrq3 locus
separately from strains with the D genotype. The influence of load
on weight change was much stronger for strains with the
susceptible D genotype than strains with the resistant B genotype
(described further in Methods). Because of the genotype-specific
switching between pathogen load and weight change in the model,
we expanded this analysis to 197 BXD mice and correlated the
weight loss with pathogen load in individual mice according to the
genotype at the Ctrq3 locus (Figure 7). Overall, mice with the B
genotype had lower pathogen load compared to mice with a D
genotype, although a considerable overlap existed. The mice with
the B genotype were tolerant of increases in pathogen burden
whereas mice with D genotype lost more weight with increases in
pathogen burden as demonstrated by the differences in the slope of
the load to weight linear regression lines (p=0.02).
Discussion
Individualized medicine requires the capability of predicting an
individual’s susceptibility to diseases and response to medical
treatments, based on genetic profile. Individual differences in
disease susceptibility and response to therapeutic interventions are
complex phenotypes modulated by genetic factors. We formulated
an approach using Bayesian networks to model the pathways
through which gene variants operate on phenotypes. Results of
our study demonstrate experimental validation of the combined
Figure 1. Association of the Ctrq3 locus with immune parameters and disease status. QTL mapping results for (A) day 6 weight, (B)
neutrophils, (C) macrophage activation status, (D) C. psittaci load, and (E) G-CSF on chromosome 11. Ctrq3 is located near 58 Mb on chr 11. Significant
(genome-wide adjusted p,0.05) and suggestive (adjusted p,0.63) QTLs are indicated by the solid red and grey lines, respectively. Blue lines indicate
the likelihood-ratio statistic (LRS) that the phenotype is associated with the genomic locus. The colored lines following the trend of the LRS show the
additive effect of the influence of the locus, with red lines indicating that D alleles increase trait values, while green alleles indicate that B alleles
increase trait values.
doi:10.1371/journal.pone.0033781.g001
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pathway modeling and disease prediction. This approach provides
a way to develop models for designing genetic association studies
that can define causal pathways with the predictive power required
in individualized medicine.
We had previously demonstrated that Ctrq3 controls systemic C.
psittaci disease outcome and found an association with IRG
polymorphisms. While IRGs have cell autonomous functions of
pathogen restriction, the immunological pathway that links this
genotype to phenotype has not been defined. It has recently been
reported that infected hosts employ two different strategies to
defend themselves against pathogens—resistance and tolerance
[25,26,27]. Resistance is defined as the ability to limit pathogen
burden, whereas tolerance is defined as the ability to limit the
damage caused by a given pathogen burden [28,29]. While most
studies on genetic susceptibility to infectious diseases implicate
resistance as a mechanism of host protection, there are several
examples of genetic tolerance to infection in animal models
[29,30,31].
In this study, we predicted that Ctrq3 conferred resistance but
with relatively little impact on weight change. We also predicted
an expanded role for Ctrq3 that included macrophage activation
and weight change. Indeed mice with a B6 genotype at the Ctrq3
locus tended to have a lower pathogen load than mice with D2
genotype and thus were more resistant. However, there was
significant variability in the pathogen load within mice with the
same genotype suggesting the presence of other factors that affect
resistance. The mechanism of resistance by Ctrq3 is likely to be due
to the cell autonomous bactericidal functions of the B6 derived
Irgb10 and Irgm2 genes given results of our previous ex vivo siRNA
experiments [5,6,7]. On the other hand, we found that mice with a
B6 genotype at the Ctrq3 locus can maintain body weight over a
wide range of pathogen load and thus have tolerance to C. psittaci
infection. In contrast, mice with a D2 genotype lost weight as a
function of increased pathogen burden and were thus less tolerant.
The molecular basis of tolerance is still unclear.
An obvious limitation of our model is that we are assessing the
function of the 2 MB Ctrq3 locus. This locus encodes three IRGs
(Irgb10, Irgm2, and Irgm3), 18 other genes, as well as non-coding
regions with unknown functions. While IRGs remain a primary
candidate given its association with immunoregulatory functions
[13,14,15,16,32,33], it is possible that resistance and tolerance is
Figure 2. A QTL on chromosome 1 regulating cytokines. QTL mapping results for (A) GM-CSF, (B) IL-1a, (C) MIP-1a, (D) MIP-1b, and (E) MIP-2 on
chromosome 1. Significant (genome-wide adjusted p,0.05) and suggestive (adjusted p,0.63) QTLs are indicated by the solid red and grey lines,
respectively. Blue lines indicate the likelihood-ratio statistic (LRS) that the phenotype is associated with the genomic locus. The colored lines
following the trend of the LRS show the additive effect of the influence of the locus, with red lines indicating that D alleles increase trait values, while
green alleles indicate that B alleles increase trait values.
doi:10.1371/journal.pone.0033781.g002
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Furthermore, the exact nature of the B6 and D2 Irgm2 alleles (e.g.
‘‘wildtype,’’ loss-of-function, hypomorph, constitutively active, etc)
is unclear and warrant additional biological validation.
While the mechanism of tolerance is unclear, our model
suggests that mice that do not recruit activated macrophages to the
site of infection have an increased number of recruited neutrophils
and more severe disease as evidenced by greater weight loss.
Specifically, Bayesian analysis predicted that mice with a D
genotype at the Ctrq3 locus would lose less weight if neutrophils
were depleted (day 6 to day 0 weight ratio: 0.83 for mice without
neutrophil depletion and 0.89 with neutrophils depleted) without
any change in pathogen load. This prediction was consistent with
our previous observations where Cxcr2 knockout mice that cannot
recruit neutrophils to the site of infection, survived challenge
without any detectible changes in pathogen load. In contrast, the
BALB/c wild type strain succumbed to infection with significant
neutrophil recruitment in a manner similar to the D2 strain [7].
We speculate that in our model, loss of tolerance leads to
uncontrolled inflammation and severe disease high-lighted by
neutrophil influx.
Interestingly, we found that macrophage depleted B6 mice have
a reduced number of C. psittaci in the infected peritoneal cavity;
whereas macrophage depleted D2 mice had a greater number. We
also found that after macrophage depletion, C. psittaci load in the
liver of D2 mice increased by 2 logs whereas loads were similar in
the liver of B6 mice. We speculate that in B6 mice, loss of a growth
niche led to a decrease in pathogen load, whereas the apparent
increase in pathogen load in the peritoneal cavity in D2 mice is
being supported by an increase in C. psittaci growth in the
surrounding tissues. While this indicates there may be a difference
in tissue/cell tropism between B6 and D2 mice, the underlying
mechanism is unknown at this point.
There are clear limitations of our model and approach. First, we
are limited by the variables we chose to screen, which did not
account for various other cell types, cytokines, physiological
parameters, etc. Second, we are limited by the dynamic process of
infectious diseases, which include the important variable of time,
where our longitudinal analyses were limited (,1 week) due to the
severity of disease in D2 mice. Third, we are limited by the nature
of the intervention we can employ. In our model, we found that
macrophage activation, which occurs gradually over the course of
infection, was an important variable that determines disease
outcome. In our validation experiment, we eliminated macro-
phages prior to infection in order to simulate the extreme end of
this variable, which may have led to activation of alternative
pathways or immune cells. Despite these limitations, our results
demonstrate a proof of principal model of how genetic mapping
and network modeling can be combined to identify causal
pathways underlying infectious disease susceptibility.
Figure 3. The correlation network of immune parameters during Chlamydia infection in BXD mice. Correlation network linking BXD
genotypes (Ctrq3 and rs13476293), C. psittaci load, inflammatory responses, cytokine profiles, IRGM2 protein expression pattern, and weight change
after C. psittaci infection in BXD strains. Positive (red) and negative (blue) correlations between variables with magnitudes of Pearson’s correlation
coefficient greater than 0.6 (dashed lines) and 0.7 (solid lines) are shown.
doi:10.1371/journal.pone.0033781.g003
Figure 4. Structure of Bayesian network (BN) model of C.
psittaci infection. The number next to each directed arc of the BN
indicates the confidence (posterior probability) in the arc after model
averaging as described in the Methods.
doi:10.1371/journal.pone.0033781.g004
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Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol (internal protocol number 1709R1) was approved by the
Animal Care and Use Committee of the University of Tennessee
Health Science Center (PHS assurance# - A-3325-01). No
surgical procedures were performed. All efforts were made to
minimize suffering.
Infection and sample collection
Chlamydia psittaci infection: C. psittaci 6BC was propagated in L
cells, titrated and stored at 280Cu. Intraperitoneal infection with
C. psittaci 6BC (10
4 IFU) was performed using the same stock
source to minimize variations across experiments. 8–16 week old
male mice (C57BL/6J, and 40 BXD strains) were infected in
groups of 2 mice/strain. Infected mice were monitored daily for
weight changes. On days 3 or 6-post infection, mice were
euthanized to obtain peritoneal lavage samples for pathogen load,
flow cytometry, and cytokine analysis. Additional mice, totaling
197 mice representing 56 BXD strains, were infected with C.
psittaci 6BC (10
4 IFU) and monitored for weight changes and
euthanized on day 6 for IFU analysis.
Assessment of immune phenotypes
Chlamydia psittaci load. Titration was performed by a cell
culture based IFU assay for day 6 samples as previously
described [7]. DNA was extracted from 1 ml of peritoneal
lavage fluid from day 3 and C. psittaci load was measured as a
ratio of C. psittaci ompA DNA/host GAPDH by quantitative
DNA PCR.
Flow cytometry. Standard methods were used as described
previously [7]. Briefly, murine peritoneal exudates were
blocked with Fc block and incubated with fluorochrome-
conjugated antibodies. The following antibodies were used:
Macrophage marker; F4/80-APC, Neutrophil marker; Ly6G
(clone IA8)-PE, and MHC class II marker; IA/IE-PE. Data was
expressed as percent of macrophages or neutrophils in the
entire population. MHC class II expression was used as a
marker for macrophage activation status and data was
expressed as percent of F4/80 positive cells that were also
positive for IA/IE.
Cytokine analysis. Peritoneal lavage supernatants were
analyzed using the Luminex based Mouse 32-plex kit to analyze
levels of 32 cytokines (CATALOG).
Western blot analysis. Peritoneal lavage specimens were
analyzed by Western blot analysis using standard methods with
GTPI antibody (M-14) Santa Cruz (sc-11088) and secondary
antibody using Goat true blot (eBioscience 18-8814-31).
Figure 5. Predictions of the BN as a function of genotype and macrophage intervention. (A and B) Discretized p of the BN as a function of
genotype at Ctrq3. BXD strains with the susceptible, D, genotype at the IRG locus tend to have lower MAS and weights and higher levels of
neutrophils and pathogen load. (C and D) Discretized p effect of interventional depletion of macrophages on the values of variables in the BN.
doi:10.1371/journal.pone.0033781.g005
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QTL mapping. Quantitative trait locus (QTL) mapping was
performed for 17 cytokine profiles that exhibited variation across
strains; immune responses including levels of neutrophils,
macrophages, and macrophage activation status (MAS); and
weight change of BXD strain infection with C. psittaci with the
GeneNetwork (www.genenetwork.org). Single marker regression
was performed across the entire mouse chromosome at 3795
markers typed across BXD strains. A likelihood ratio statistic
(LRS) was calculated at each marker comparing the hypothesis
that the marker is associated with the phenotype with the null
hypothesis that there is no association between marker and
phenotype. Genome-wide significance was determined by
performing 1000 permutations. Two significant (genome-wide p-
value,0.05) QTLs were found: one QTL was located near 55 Mb
on chromosome 11 and was associated with weight change, MAS,
pathogen load, and neutrophil levels (Figure 1), while the other
significant QTL was located on chromosome 1 near 190 Mb and
was associated with several cytokines (Figure 2).
Bayesian network modeling. Structural learning of the
Bayesian network was performed using the R package deal (http://
cran.r-project.org/web/packages/deal/index.html). The network
was constructed from data for C57BL/6J and 40 BXD strains
using one discrete node, representing the Ctrq3 genotype and
IRGM2 protein expression pattern, and four continuous nodes
(neutrophils, C. psittaci load, macrophage activation status, and the
ratio of the weight of the mice 6 days after infection to the weight
before infection), which were modeled with conditional Gaussian
distributions. The Bayesian network score [34], which is basically
a version of the BDe scoring metric [35] extended to include
conditional Gaussian distributions, was calculated in deal for all,
except those that violated two restrictions. First, potential models in
which the genotype node was the child of any other nodes in the
network were not considered. This restriction does not require that
the genotype node be the parent of the other nodes, as model
structures in which continuous nodes were independent of genotype
were allowed. Second, the weight node could not be the parent of
any other node. The Bayesian score metric inherently handles the
problem of over fitting data to complex models [36]. However,
selecting a single best network model and ignoring all other models
may still lead to over-fitting the data. Model averaging can be used
to reduce this risk [37]. An indicator function f is defined as: if a
network G learned from data D has the feature (here a feature is a
directed edge representing a regulatory relationship), f(G)~1,
otherwise, f(G)~0. The posterior probability of a feature is
P(f(G)DD)~
X
G
f(G)P(GDD). This probability reflects our
confidence in the feature f. We calculated the posterior
probability of features by averaging over all possible models, with
the restrictions noted above. All features with a posterior probability
greater than 0.5 were included in the network.
The reproducibility of the structure learning method was
investigated with the use of simulated data. Briefly, the model
learned for the original network was used to generate simulated
data sets. Then, the structure learning method was repeated with
the simulated data sets and the network structures learned from
the simulated data sets were compared to the structure of the
original network. A high correspondence between the simulated
structures and the original structure indicates that the size of the
original data set was sufficient to learn the structure of the
network. To create the simulated data, parameter learning of the
network was performed with the maximum likelihood estimator
provided in the Bayes Net Toolbox [38], available for download
at: http://code.google.com/p/bnt/. Before the parameters of the
network were learned, the data for the four continuous nodes was
normalized to have a mean of 0 and standard deviation of 1.
1000 simulated data sets with 41 samples were then generated
with the sample_bnet function of the Bayes Net Toolbox. The
structure learning method used to learn the original network was
then used for each of the simulated data sets. The edges in the
original network were highly reproduced in the simulated data
(Figure S1).
Prediction of effects of macrophage depletion. We
predicted the effects of intervention using a hybrid Bayesian
network including both the discrete genotype node and continuous
nodes modeled with conditional Gaussian distributions with the
Bayes Net Toolbox. The parameters of the network were learned
with a maximum likelihood approach. Macrophage depletion is an
external intervention to the model. The intervention sets the value
of the MAS node and relieves it from the influence of its parent
node. Therefore, prediction was performed by removing the link
Ctrq3/IRGM2RMAS and setting macrophage activation status to
the minimum value observed in the data used for parameter
learning [action do (MAS=MIN), where MIN=0,032 is the
minimum observed MAS value]. The probabilistic inference was
executed using the Bayes Net Toolbox. The effects of macrophage
depletion on the parameters of the conditional Gaussian
Figure 6. Impact of macrophage depletion on the course of C. psittaci infection in B6 and D2 strains. B6 and D2 mice received either
liposome clodronate or liposome PBS iv (day 21 post infection) and i.p. (day 21, 1, and 3 post infection) and infected with C. psittaci 10
4 IFU
intraperitoneally (N=5/group). Mice were monitored daily for weight (A) and appearance. Data points where differences in weight met statistical
significance are indicated in asterix (* p=0.003, ** p=3.7610E-5, p=0.04). Clodronate treated D2 strain became moribund on day 4 and B6 on day 5
post infection and were euthanized. Brackets and p values are provided to indicate differences in, number of neutrophils (B), and C. psittaci load (C)
between clodronate (black) and liposome (white) treated mice for both B6 and D2 strains. Data is representative of two experiments.
doi:10.1371/journal.pone.0033781.g006
Figure 7. Genetic resistance and tolerance to Chlamydia
infection in mice. Plot of weight change as a function of IFU for
197 BXD mice infected with C. psittaci. Mice with the susceptible D
genotype at the Ctrq3 (open symbols) lose weight as pathogen load
increases, while mice with the resistant B genotype at the Ctrq3 marker
(filled circles) do not. The slopes of the linear regression lines for the B
(solid line) and D (dashed line) data are significantly different (p=0.02).
doi:10.1371/journal.pone.0033781.g007
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S2. Depletion of macrophages causes increases in the levels of
neutrophils and pathogen load and decreased weight. The
magnitude of these changes is larger for mice with the D
genotype at Ctrq3.
Bayesian network cross-validation. Leave-one-out cross
validation was also used to test the performance of the hybrid
Bayesian network. For each test strain, parameter learning of the
remaining 40 strains and inference was performed with the Bayes
Net Toolbox with the methods mentioned above. To evaluate the
quality of the continuous predictions, we used the Q
2 parameter
[39], which is given by:
Q2~1{
X
(yi{^ y yi)
2
X
(yi{  y y)
2
where yi is the value of the ith sample, y
^
i is the predicted value of
the ith sample, and   y y is the sample mean. The values of Q
2 for
MAS, neutrophil level, pathogen load, and weight were 0.51, 0.59,
0.45, and 0.68, respectively. Additionally, we discretized the
original data and the predictions from the leave-one-out-cross
validation for each strain and used this discretized data to test the
accuracy of the predictions. A threshold for each of the continuous
variables was determined by averaging the mean value of the
original data for all strains with the B genotype and the mean
value for all strains with the D genotype. Then, the continuous
variables for the original data and the predictions were classified as
being either High or Low through comparison with these
threshold values for each strain. The accuracy was then
determined by dividing the number of predictions that matched
the original data by the total number of strains. For MAS,
neutrophil level, pathogen load, and weight, the accuracy was
accuracy 85%, 93%, 80%, and 88%, respectively.
Strain dependent influence of pathogen load on weight change
after infection: To test if the arc from pathogen load to weight
ratio was genotype dependent, the data for mice with B and D
genotypes at the Ctrq3 locus were separated. As each data set only
contained data from strains with one genotype, the genotype node
was removed from the network, and the structure of the network,
using model averaging of an exhaustive search of possible
structures with deal, was learned for both the B and D data. For
strains with the D genotype, a directed edge from pathogen load to
weight ratio had a posterior probability of 0.64, while the same
edge for strains with the B genotype had a posterior probability of
only 0.16, indicating that weight change was dependent on C.
psittaci load only for strains with the susceptible D genotype. This
conclusion was confirmed by grouping the pathogen load and
weight ratio for a total of 197 mice into B and D groups using the
genotype at Ctrq3. Slopes of the linear regression lines of pathogen
load vs. weight ratio for each group were calculated and compared
using the analysis of covariance tool in Matlab 7.8 (R2009a). The
slopes of the lines were significantly different with a p-value of
0.02.
Validation experiments
B6 and D2 mice were each grouped into two groups (N=5) that
received clodronate containing liposome or PBS containing
liposome injections on day 21, 1, 3, 5 (day 21: 200 uL iv,
200 uL i.p., day 1, 3, 5: 200 uL i.p.) [40]. All mice were infected
on day 0 with C. psittaci 6BC at 10
4 IFU i.p. and monitored daily
for weight changes. On day 6 post infection, mice were euthanized
and peritoneal lavage was obtained. The peritoneal lavage was
processed for pathogen load, cell population (number of
neutrophils and macrophages) and macrophage activation status
by flow cytometry as described before. The total number of cells in
the lavage was enumerated by cytometer and total numbers of
neutrophils were calculated.
Supporting Information
Figure S1 Reproducibility of network structures. The
number next to each edge is the fraction of times that the edge was
present in the structure of 1000 simulated data sets. The simulated
data sets were generated from the parameters of the original
network and contained 41 samples, the same number of samples as
in the original data set. The structure learning method used for the
simulated data sets was the same as that used for the original
network. No edges not present in the original network occurred in
more than 0.29 of the simulated data sets.
(TIF)
Figure S2 Effect of macrophage depletion on predic-
tions of continuous data by Bayesian network. Probability
density functions for Gaussian distributions describing the
predicted values of macrophage activation status (A), pathogen
load (B), neutrophils (C), and weight (D) in normal mice (solid
lines) and in mice with depleted macrophages after treatment with
clodronate (dashed lines). The effect of macrophage depletion has
a much larger effect on predictions for mice with the resistant B6
genotype (blue lines) than with the susceptible D2 genotype
(orange lines).
(TIF)
Table S1 Mean values of Bayesian network predictions
as a function of genotype and macrophage intervention.
(DOC)
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